Prognostic Model for Cisplatin Resistance in Oral Cancer
Author Information
Author(s): Lu Rong, Yang Qian, Liu Siyu, Sun Lu
Primary Institution: Shengli Oilfield Central Hospital, Dongying, Shandong, China
Hypothesis
This study aims to screen for a cisplatin-resistance related prognostic signature in oral squamous cell carcinoma (OSCC) and assess its correlation with the immune microenvironment.
Conclusion
The identified model genes and immune cells may help predict prognosis and chemoresistance in OSCC.
Supporting Evidence
- Seven drug-resistant genes were identified as independent prognostic factors.
- Fifteen immune cells showed statistically significant differences in infiltration levels between risk groups.
- The study constructed a risk score model to predict survival rates.
Takeaway
Researchers found some genes that can help predict how well patients with oral cancer will respond to a common treatment called cisplatin.
Methodology
Gene expression data were analyzed using univariate Cox regression and LASSO regression to construct a survival prognosis model.
Participant Demographics
The study included 255 OSCC samples with survival and clinical information.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website